Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency
Feb 28, 2018 12:01 pm UTC| Business
28 February 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP), the international...
Evogene Reports Fourth Quarter and Full Year 2017 Financial Results
Feb 28, 2018 12:01 pm UTC| Business
REHOVOT, Israel, Feb. 28, 2018 -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology...
Snipp Announces $500,000 Investment From Asian Strategic Investor
Feb 28, 2018 12:01 pm UTC| Business
TORONTO, Feb. 28, 2018 -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB: SNIPF) (TSX-V: SPN), a global provider of digital marketing promotions, rebates and loyalty solutions, is pleased to announce the...
Feb 28, 2018 12:01 pm UTC| Business
Miami, FL, Feb. 28, 2018 -- Omni Health, Inc. (OTC:OMHE), a vertically integrated healthcare company dedicated to the development of pharmaceuticals, anti-aging products, and biotech engineering, today announced ...
Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results
Feb 28, 2018 12:01 pm UTC| Business
CHESTERBROOK, Pa., Feb. 28, 2018 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the quarter and...
Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
Feb 28, 2018 12:01 pm UTC| Business
NEW HAVEN, Conn., Feb. 28, 2018 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today it intends...
Feb 28, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 28, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic...